LONDON (Reuters) – The first people vaccinated with an experimental Ebola shot being developed by Merck and NewLink have had no serious side effects so far, but a few experienced mild fever, Swiss researchers said on Tuesday.
The shot, one of several being fast-tracked through clinical…
No serious side effects in Merck/Newlink Ebola vaccine test
No comments:
Post a Comment